Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;48(6):2714-2723.
doi: 10.1002/mp.14770. Epub 2021 Apr 25.

An artificial intelligence-driven agent for real-time head-and-neck IMRT plan generation using conditional generative adversarial network (cGAN)

Affiliations

An artificial intelligence-driven agent for real-time head-and-neck IMRT plan generation using conditional generative adversarial network (cGAN)

Xinyi Li et al. Med Phys. 2021 Jun.

Abstract

Purpose: To develop an artificial intelligence (AI) agent for fully automated rapid head-and-neck intensity-modulated radiation therapy (IMRT) plan generation without time-consuming dose-volume-based inverse planning.

Methods: This AI agent was trained via implementing a conditional generative adversarial network (cGAN) architecture. The generator, PyraNet, is a novel deep learning network that implements 28 classic ResNet blocks in pyramid-like concatenations. The discriminator is a customized four-layer DenseNet. The AI agent first generates multiple customized two-dimensional projections at nine template beam angles from a patient's three-dimensional computed tomography (CT) volume and structures. These projections are then stacked as four-dimensional inputs of PyraNet, from which nine radiation fluence maps of the corresponding template beam angles are generated simultaneously. Finally, the predicted fluence maps are automatically postprocessed by Gaussian deconvolution operations and imported into a commercial treatment planning system (TPS) for plan integrity check and visualization. The AI agent was built and tested upon 231 oropharyngeal IMRT plans from a TPS plan library. 200/16/15 plans were assigned for training/validation/testing, respectively. Only the primary plans in the sequential boost regime were studied. All plans were normalized to 44 Gy prescription (2 Gy/fx). A customized Harr wavelet loss was adopted for fluence map comparison during the training of the PyraNet. For test cases, isodose distributions in AI plans and TPS plans were qualitatively evaluated for overall dose distributions. Key dosimetric metrics were compared by Wilcoxon signed-rank tests with a significance level of 0.05.

Results: All 15 AI plans were successfully generated. Isodose gradients outside of PTV in AI plans were comparable to those of the TPS plans. After PTV coverage normalization, Dmean of left parotid (DAI = 23.1 ± 2.4 Gy; DTPS = 23.1 ± 2.0 Gy), right parotid (DAI = 23.8 ± 3.0 Gy; DTPS = 23.9 ± 2.3 Gy), and oral cavity (DAI = 24.7 ± 6.0 Gy; DTPS = 23.9 ± 4.3 Gy) in the AI plans and the TPS plans were comparable without statistical significance. AI plans achieved comparable results for maximum dose at 0.01cc of brainstem (DAI = 15.0 ± 2.1 Gy; DTPS = 15.5 ± 2.7 Gy) and cord + 5mm (DAI = 27.5 ± 2.3 Gy; DTPS = 25.8 ± 1.9 Gy) without clinically relevant differences, but body Dmax results (DAI = 121.1 ± 3.9 Gy; DTPS = 109.0 ± 0.9 Gy) were higher than the TPS plan results. The AI agent needed ~3 s for predicting fluence maps of an IMRT plan.

Conclusions: With rapid and fully automated execution, the developed AI agent can generate complex head-and-neck IMRT plans with acceptable dosimetry quality. This approach holds great potential for clinical applications in preplanning decision-making and real-time planning.

Keywords: artificial intelligence; conditional generative adversarial network; deep learning; fluence map prediction; head-and-neck cancer; intensity-modulated radiation therapy; treatment planning.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians. 2020;70:7-30.
    1. Adelstein D, Gillison ML, Pfister DG, et al. NCCN guidelines insights: head and neck cancers, version 2.2017. J Natl Compr Canc Netw. 2017;15:761-770.
    1. Network NCC. NCCN clinical practice guidelines in oncology: Head and neck cancers version. 2013;2:2013.
    1. Borras JM, Barton M, Grau C, et al. The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project. Radioth Oncol. 2015;116:45-50.
    1. Quan EM, Li X, Li Y, et al. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2012;83:1169-1178.

LinkOut - more resources